Immune Checkpoint Inhibitors and Novel Immunotherapies focus on blocking immune suppression mechanisms used by cancer cells, allowing the immune system to effectively attack tumors.
This field has revolutionized cancer treatment through breakthroughs in immuno-oncology.
Several specialized areas are studied within this field, including:
• PD-1 / PD-L1 Inhibitors
• CTLA-4 Blockade
• Immune Activation Pathways
• Combination Immunotherapy
• Resistance Mechanisms
• Novel Immune Targets
• Therapeutic Antibodies
• Immune Escape Mechanisms